Inovio Pharma (INO) Misses Q4 EPS by 65c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.29 --0%
EPS Growth %: +75.9%
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +75.9%
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.65). Revenue for the quarter came in at $120 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Viatris (VTRS) at Outperform
- AstraZeneca extends Young Health Programme with $100m total investment
- Oppenheimer Starts ANI Pharmaceuticals (ANIP) at Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
